FDA official logo
GSRS logo
PFDA official logo

MAPATUMUMAB

  • UNII: WZ1025JPGR
  • Preferred Substance Name: MAPATUMUMAB

  • 658052-09-6
  • HGS1012
  • HGS-1012
  • HGS-ETR1
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN CYTOKINE RECEPTOR DR4 (DEATH RECECEPTOR 4)) (HUMAN MONOCLONAL TRM-1 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL TRM-1 .LAMBDA.-CHAIN, DIMER
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN CYTOKINE RECEPTOR DR4 (DEATH RECECEPTOR 4)) (HUMAN MONOCLONAL TRM-1 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL TRM-1 .LAMBDA.-CHAIN, DIMER
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN CYTOKINE RECEPTOR DR4 (DEATH RECEPTOR 4)) (HUMAN MONOCLONAL TRM-1 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL TRM-1 .LAMBDA.-CHAIN, DIMER
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN TRAIL-R1) (HUMAN MONOCLONAL TRM-1 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL TRM-1 .LAMBDA.-CHAIN, DIMER
  • MAB HUMAN (IGG1) ANTI O00220 (TR10A_HUMAN) (HGS1012)
  • MAPATUMUMAB [INN]
  • MAPATUMUMAB [USAN]
  • MAPATUMUMAB [WHO-DD]
  • TRAIL-R 1MAB
  • TRAIL-R1 MAB
  • TRM-1
  • TRM-1 HGS-ETR1

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.